This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Oct;79(4):e154-e155.

doi: 10.1016/j.jhep.2023.01.021. Epub 2023 Feb 1.

A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?

Sinead Carlson¹, Karl Vaz², Adam Peterson³

Affiliations

Affiliations

¹ Department of Gastroenterology, Monash Health, School of Clinical Sciences, Monash University, Australia. Electronic address: sinead.carlson@monashhealth.org.
² Department of Gastroenterology, Alfred Health, Central Clinical School, Monash University, Australia; Department of Gastroenterology, Austin Health, Australia.
³ Department of Gastroenterology, Monash Health, School of Clinical Sciences, Monash University, Australia.

PMID: 36736735
DOI: 10.1016/j.jhep.2023.01.021

Comment

A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?

Sinead Carlson et al. J Hepatol. 2023 Oct.

. 2023 Oct;79(4):e154-e155.

doi: 10.1016/j.jhep.2023.01.021. Epub 2023 Feb 1.

Authors

Sinead Carlson¹, Karl Vaz², Adam Peterson³

Affiliations

¹ Department of Gastroenterology, Monash Health, School of Clinical Sciences, Monash University, Australia. Electronic address: sinead.carlson@monashhealth.org.
² Department of Gastroenterology, Alfred Health, Central Clinical School, Monash University, Australia; Department of Gastroenterology, Austin Health, Australia.
³ Department of Gastroenterology, Monash Health, School of Clinical Sciences, Monash University, Australia.

PMID: 36736735
DOI: 10.1016/j.jhep.2023.01.021

No abstract available

PubMed Disclaimer

Comment in

Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?'.
Yang H, Kim JH, Han JW, Lee SK, Jang JW. Yang H, et al. J Hepatol. 2023 Oct;79(4):e155-e157. doi: 10.1016/j.jhep.2023.06.005. Epub 2023 Jun 27. J Hepatol. 2023. PMID: 37385474 No abstract available.

Comment on

A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance.
Yang H, Bae SH, Nam H, Lee HL, Lee SW, Yoo SH, Song MJ, Kwon JH, Nam SW, Choi JY, Yoon SK, Jang JW. Yang H, et al. J Hepatol. 2022 Sep;77(3):632-641. doi: 10.1016/j.jhep.2022.03.032. Epub 2022 Apr 7. J Hepatol. 2022. PMID: 35398462

Similar articles

Reply to: 'A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Has the correct patient cohort been targeted?'.
Yang H, Kim JH, Han JW, Lee SK, Jang JW. Yang H, et al. J Hepatol. 2023 Oct;79(4):e155-e157. doi: 10.1016/j.jhep.2023.06.005. Epub 2023 Jun 27. J Hepatol. 2023. PMID: 37385474 No abstract available.
A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance: Considerations.
Tang Y, Chen Y, Chen HN. Tang Y, et al. J Hepatol. 2022 Dec;77(6):1722-1724. doi: 10.1016/j.jhep.2022.05.032. Epub 2022 Jun 9. J Hepatol. 2022. PMID: 35690263 No abstract available.
Antiviral therapy, HBsAg seroclearance and late recurrence of hepatitis B-related hepatocellular carcinoma.
Liu SY, Yuan C, Tong XM. Liu SY, et al. J Hepatol. 2022 Nov;77(5):1471-1472. doi: 10.1016/j.jhep.2022.07.005. Epub 2022 Jul 19. J Hepatol. 2022. PMID: 35863489 No abstract available.
[Effect of chronic hepatitis B virus DNA negative transformation and HBsAg clearance on the occurrence of hepatocellular carcinoma].
Zhou JL, Wang BQ, Shi YW, You H. Zhou JL, et al. Zhonghua Gan Zang Bing Za Zhi. 2019 Nov 20;27(11):831-833. doi: 10.3760/cma.j.issn.1007-3418.2019.11.004. Zhonghua Gan Zang Bing Za Zhi. 2019. PMID: 31941236 Review. Chinese.
Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis.
Anderson RT, Choi HSJ, Lenz O, Peters MG, Janssen HLA, Mishra P, Donaldson E, Westman G, Buchholz S, Miller V, Hansen BE. Anderson RT, et al. Clin Gastroenterol Hepatol. 2021 Mar;19(3):463-472. doi: 10.1016/j.cgh.2020.05.041. Epub 2020 May 27. Clin Gastroenterol Hepatol. 2021. PMID: 32473348

See all similar articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information